New Recruiting Trial: Androgenic Alopecia TH07 Clinical Trial

WHY IT MATTERS

This Phase 3 trial is actively recruiting now, meaning if you have androgenic alopecia, you could potentially enroll and access an investigational treatment while contributing to evidence that could lead to FDA approval.

Triple Hair Inc is recruiting patients for a Phase 3 clinical trial testing a new treatment called TH07 for androgenic alopecia, commonly known as male or female pattern baldness. This is a large-scale study to confirm whether TH07 works better than current treatments. If you have pattern hair loss, you may be eligible to join and help test this potential new therapy.

NCT ID: NCT07435012 Title: Androgenic Alopecia TH07 Clinical Trial Status: RECRUITING Phase: PHASE3 Sponsor: Triple Hair Inc Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT07435012 Source: UniteRare clinical trials database

YOU CAN ACT ON THIS

Visit clinicaltrials.gov/study/NCT07435012 to check eligibility requirements and find recruiting sites near you, or ask your dermatologist if this trial might be appropriate for your situation.